Categories: CancerHealthcareNews

AccessHope Selected Best Virtual Care Solution Provider by MedTech Breakthrough

Prestigious International Award Recognizes AccessHope for AI-Assisted Solution that Connects People with Cancer to Expertise at Top Cancer Centers

DUARTE, Calif., May 8, 2025 /PRNewswire/ — AccessHope, LLC, a company changing the way leading-edge cancer expertise is delivered, today announced that it has been selected as the Best Virtual Care Solution Provider in the Ninth Annual MedTech Breakthrough Awards program.

MedTech Breakthrough, an independent market intelligence organization, recognized AccessHope for its virtual cancer support benefit that remotely connects individuals with cancer and their treating oncologists to subspecialist expertise at National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers. By leveraging its nationwide network of cancer specialists and an artificial intelligence (AI)-assisted case review process, AccessHope is mobilizing the latest cancer insights to support local oncologists in developing precise treatment plans for their patients.

“We are extremely proud to be recognized by MedTech Breakthrough as this year’s best virtual care solution provider for our innovative, tech-enabled approach to improving cancer care,” said AccessHope Chief Executive Officer Brad Kreick. “Research shows that outcomes are significantly better at NCI-Designated Comprehensive Cancer Centers, yet most people with cancer aren’t treated there because of geographical barriers. Our partnerships with leading cancer centers across the country enable our members to remotely access the latest knowledge on advancements in cancer care from the nation’s top experts.”

AccessHope is bridging the knowledge gap between community oncologists and academia by remotely connecting local physicians with subspecialist expertise from NCI-Designated Comprehensive Cancer Centers to review treatment plans. This first-of-its-kind virtual cancer support benefit is used by more than 70 Fortune 500 companies, two of the nation’s largest health plans, and several oncology advocacy and navigation solutions. It gives members with cancer and their community oncologists access to renowned expertise, regardless of where they live. This remote model assists with all cancer types and stages, allowing individuals and their families to benefit from the latest insights from the comfort of their own home.

The MedTech Breakthrough Awards recognize the top companies, technologies and products in the global health and medical technology market. The mission of the awards is to honor excellence and recognize the creativity, innovation, hard work and success of digital health and medical technology companies, services and products around the globe. AccessHope was selected out of over 4,500 nominations worldwide and honored alongside an impressive list of Fortune 100 companies and startups, including Johnson & Johnson, Abbott, Welldoc, Abbott, ŌURA, Included Health, Medtronic, DocGo, Zimmer Biomet, Elsevier, Nike Training Club, Sleep Number Corporation, Medidata, IQVIA and others.

About AccessHope
AccessHope, LLC, believes in putting the ever-growing body of cancer knowledge to work for the greater good. The company delivers a revolutionary cancer benefit that is changing the way leading-edge expertise is delivered. Through collaborations with City of Hope, Dana-Farber Cancer Institute, Emory Healthcare and Winship Cancer Institute of Emory University, Fred Hutch Cancer Center, Johns Hopkins Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and UT Southwestern Medical Center and its Harold C. Simmons Comprehensive Cancer Center, AccessHope shares the latest discoveries in cancer care with employees’ plans and local oncologists to help as they develop precise plans for treatment. The company brings the vast expertise of major medical centers to benefit people near and far. They never have to switch doctors. They never have to leave home. It’s simply a better approach to treating cancer. An organization founded by City of Hope, AccessHope offers the benefit to approximately nine million members through more than 700 employers, including over 70 Fortune 500 companies. For more information about AccessHope, visit myaccesshope.org and follow us on LinkedIn and Twitter.

View original content to download multimedia:https://www.prnewswire.com/news-releases/accesshope-selected-best-virtual-care-solution-provider-by-medtech-breakthrough-302449528.html

SOURCE AccessHope

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

11 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

11 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago